Given that anxiety symptoms are often accompanied by pain in the clinical setting, this work has important clinical implications, as it suggests that oxytocin and the PVN‐CeA oxytocin inputs are promising targets for therapeutic intervention to prevent comorbidity of pain and anxiety. This evidence concerns the gene OXT and Anxiety.